OCC Commends FDA for Second Obesity Medication Approval
This Post has No Comments
Obesity Care Continuum (OCC) Commends Food and Drug Administration (FDA) for their Continued Proactive Support and Approval of New Obesity Treatments
Washington, DC – Today, members of the Obesity Care Continuum (OCC) commended the Food and Drug Administration (FDA) for their continued proactive approach to ensuring safe obesity treatment options for the more than 93 million Americans affected by the disease…
To view the full news release, click here.